CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...